These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis. Borucki MJ, Spritzler J, Asmuth DM, Gnann J, Hirsch MS, Nokta M, Aweeka F, Nadler PI, Sattler F, Alston B, Nevin TT, Owens S, Waterman K, Hubbard L, Caliendo A, Pollard RB, AACTG 266 Team. Antiviral Res; 2004 Nov; 64(2):103-11. PubMed ID: 15498605 [Abstract] [Full Text] [Related]
29. Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis. Dodds EM, Lowder CY, Foster RE, Avery RK, Prayson RA. Arch Ophthalmol; 1996 Jul; 114(7):896-7. PubMed ID: 8660181 [No Abstract] [Full Text] [Related]